GE

Genomictree Inc.

A molecular diagnostics company developing tests for the early detection of cancer.

228760 | KO

Overview

Corporate Details

ISIN(s):
KR7228760005
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노10로 44-6, 대전광역시

Description

Genomictree Inc. is a molecular diagnostics company that develops and commercializes products for the early detection and diagnosis of cancer. The company specializes in epigenomics, utilizing its proprietary genomic-scale discovery tools to identify DNA methylation biomarkers. Its flagship product line, EarlyTect®, offers non-invasive tests for the early screening of colorectal, lung, and bladder cancers. Additionally, Genomictree provides AccuraTect™, a companion diagnostic test for cancer. The company's mission is to improve patient quality of life and reduce medical costs through accessible and accurate early-stage cancer detection.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-12 00:00
자기주식처분결과보고서
Korean HTML 17.0 KB
2026-01-12 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.6 KB
2026-01-12 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.6 KB
2026-01-12 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.6 KB
2026-01-12 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.7 KB
2026-01-09 00:00
주요사항보고서(자기주식처분결정)
Korean HTML 30.6 KB
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean HTML 4.1 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 1.6 MB
2025-06-18 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.7 KB
2025-06-18 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.7 KB
2025-06-18 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.5 KB
2025-06-18 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.5 KB
2025-06-16 00:00
자기주식처분결과보고서
Korean HTML 16.7 KB
2025-06-11 00:00
주요사항보고서(자기주식처분결정)
Korean HTML 29.1 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean HTML 1.3 MB

Automate Your Workflow. Get a real-time feed of all Genomictree Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Genomictree Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Genomictree Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adaptive Biotechnologies Corp Logo
Decodes the adaptive immune system to develop products for diagnosing and treating disease.
United States of America
ADPT
Adeia Inc. Logo
R&D company that licenses IP for the media, entertainment, and semiconductor industries.
United States of America
ADEA
Aditxt, Inc. Logo
Acquires, develops, and deploys health technologies to address major health challenges.
United States of America
ADTX
Advanced Biomed Inc. Logo
Develops microfluidic biochip diagnostic systems for precision oncology.
United States of America
ADVB
AIM ImmunoTech Inc. Logo
Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.
United States of America
AIM
Ainos, Inc. Logo
Develops AI-driven diagnostics, immune therapeutics, and telehealth POCT devices.
United States of America
AIMD
Akero Therapeutics, Inc. Logo
Clinical-stage company developing treatments for serious metabolic diseases like MASH.
United States of America
AKRO
Aladdin Healthcare Technologies SE Logo
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
Germany
NMI
Alaunos Therapeutics, Inc. Logo
Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.
United States of America
TCRT
Aligos Therapeutics, Inc. Logo
A clinical-stage biopharmaceutical company developing therapeutics for liver and viral diseases.
United States of America
ALGS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.